Latest Articles
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise - Newswise
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise Newswise
Published: April 21, 2026, 1:10 a.m.
GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers - BioXconomy
GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers BioXconomy
Published: April 20, 2026, 2:38 p.m.
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center
Published: April 20, 2026, 1 p.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN
High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN
Published: April 20, 2026, 8:14 a.m.
Ascentage Pharma Presents Promising Cancer Research at AACR - The Clinical Trial Vanguard
Ascentage Pharma Presents Promising Cancer Research at AACR The Clinical Trial Vanguard
Published: April 20, 2026, 8 a.m.
'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' - The Mirror
'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' The Mirror
Published: April 19, 2026, 6 a.m.
Gynaecologist shares little-known ovarian cancer symptom every woman should know - Wales Online
Gynaecologist shares little-known ovarian cancer symptom every woman should know Wales Online
Published: April 19, 2026, 6 a.m.
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times
Published: April 17, 2026, 12:30 p.m.
Navigating the Clinical and Economic Burden of Endometrial Cancer - Pharmacy Times
Navigating the Clinical and Economic Burden of Endometrial Cancer Pharmacy Times
Published: April 17, 2026, 12:30 p.m.
Link copied to clipboard!